RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

Name: RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
Published: 2004
License: Public Domain

M.D. Anderson Cancer Center · 2004

ClinicalTrials.gov · Datasets · License: Public Domain · 2004

Open Source ↗

leukemia phase

leukemia, mantle cell lymphoma, myelofibrosis, relapsed or refractory acute myeloid leukemia, acute lymphocytic leukemia, chronic myeloid leukemia in blastic-phase, agnogenic myeloid metaplasia, chronic lymphocytic leukemia, t-cell leukemia, rad001, everolimus, afinitor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 838371
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.